In vivo imaging of cerebral amyloid plaque load and glucose metabolism in semantic dementia and Alzheimer's disease

被引：0
|
作者：
Drzezga, A. [1 ]
Grimmer, T. [1 ]
Henriksen, G. [1 ]
Perneczky, R. [1 ]
Stangier, I. [1 ]
Wester, H. [1 ]
Kurz, A. [1 ]
Schwaiger, M. [1 ]
机构：
[1] Tech Univ Munich, Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2006年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S156 / S157
页数：2
相关论文
共 50 条
  • [31] Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease
    Samuraki, Miharu
    Matsunari, Ichiro
    Yoshita, Mitsuhiro
    Shima, Keisuke
    Noguchi-Shinohara, Moeko
    Hamaguchi, Tsuyoshi
    Ono, Kenjiro
    Yamada, Masahito
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 48 (02) : 517 - 528
  • [32] Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism
    Yi, Dahyun
    Lee, Younghwa
    Byun, Min Soo
    Lee, Jun Ho
    Ko, Kang
    Sohn, Bo Kyung
    Choe, Young Min
    Choi, Hyo Jung
    Baek, Hyewon
    Sohn, Chul-Ho
    Kim, Yu Kyeong
    Lee, Dong Young
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [33] Multiphoton in vivo imaging of amyloid in animal models of Alzheimer's disease
    Dong, Jinghui
    Revilla-Sanchez, Raquel
    Moss, Stephen
    Haydon, Philip G.
    NEUROPHARMACOLOGY, 2010, 59 (4-5) : 268 - 275
  • [34] Imaging and in vivo quantitation of β-amyloid:: An exemplary biomarker for Alzheimer's disease?
    Nichols, Lisa
    Pike, Victor W.
    Cai, Lisheng
    Innis, Robert B.
    BIOLOGICAL PSYCHIATRY, 2006, 59 (10) : 940 - 947
  • [35] Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease
    Scheltens, Nienke M. E.
    Briels, Casper T.
    Yaqub, Maqsood
    Barkhof, Frederik
    Boellaard, Ronald
    van der Flier, Wiesje M.
    Schwarte, Lothar A.
    Teunissen, Charlotte E.
    Attali, Amos
    Broersen, Laus M.
    van Berckel, Bart N. M.
    Scheltens, Philip
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2019, 5 (01) : 492 - 500
  • [36] Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease
    Mielke, R
    Schroder, R
    Fink, GR
    Kessler, J
    Herholz, K
    Heiss, WD
    ACTA NEUROPATHOLOGICA, 1996, 91 (02) : 174 - 179
  • [37] Age at onset and regional cerebral glucose metabolism in Alzheimer's disease
    Yasuno, F
    Imamura, T
    Hirono, N
    Ishii, K
    Sasaki, M
    Ikejiri, Y
    Hashimoto, M
    Shimomura, T
    Yamashita, H
    Mori, E
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1998, 9 (02) : 63 - 67
  • [38] A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies
    Yong, S. W.
    Lee, P. H.
    Kim, Y. J.
    MOVEMENT DISORDERS, 2007, 22 : S234 - S235
  • [39] Differential deposition of amyloid β peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia
    Haglund, M
    Kalaria, R
    Slade, JY
    Englund, E
    ACTA NEUROPATHOLOGICA, 2006, 111 (05) : 430 - 435
  • [40] Differential deposition of amyloid β peptides in cerebral amyloid angiopathy associated with Alzheimer’s disease and vascular dementia
    Mattias Haglund
    Raj Kalaria
    Janet Y. Slade
    Elisabet Englund
    Acta Neuropathologica, 2006, 111 : 430 - 435
12345